Vioxx is a nonsteroidal anti-inflammatory drug that inhibits cyclooxygenase-2 (COX-2). The COX-2 enzyme controls the conversion of arachidonic acid into prostaglandin E2, a hormone that produces inflammation.
Vioxx has most recently been approved for the relief of the signs and symptoms of rheumatoid arthritis in adults. The drug was initially approved in 1999 for the relief of osteoarthritis, the management of acute pain in adults, and the treatment of primary dysmenorrhea (menstrual pain).
Vioxx is available as a tablet or in a liquid formulation.
Vioxx has most recently been approved for the relief of the signs and symptoms of rheumatoid arthritis in adults. The drug was initially approved in 1999 for the relief of osteoarthritis, the management of acute pain in adults, and the treatment of primary dysmenorrhea (menstrual pain).
Vioxx is available as a tablet or in a liquid formulation.
